Approval · Notice of Compliance 18372 · 2016
PROMETRIUM: Notice of Compliance 18372
Issued August 16, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18372
- Date
- August 16, 2016
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph in response to an advisement letter dated may 13, 2016
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROMETRIUM | 02166704 | Marketed |
Medicinal ingredients
- PROGESTERONE 100 MG per CAP